2003
DOI: 10.1002/gps.929
|View full text |Cite
|
Sign up to set email alerts
|

Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder

Abstract: Low doses of risperidone and olanzapine improve cognitive function in elderly patients with schizophrenia or schizoaffective disorder. Consistent with research in younger populations, these improvements occur in aspects of cognitive functioning related to functional outcome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
34
0

Year Published

2004
2004
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(36 citation statements)
references
References 38 publications
2
34
0
Order By: Relevance
“…Olanzapine was associated with more frequent falls in patients with dementia than Risperidone (Martin et al, 2001b), although no differences in falls were found in another similar study (Kennedy et al, 2003). No differences in clinical (Jeste et al, 2003) or cognitive (Harvey et al, 2003) outcomes were found in randomized comparisons of Risperidone and Olanzapine in elderly patients with schizophrenia or schizoaffective disorder, although weight gain was found more commonly in patients treated with Olanzapine in one of these studies (Jeste et al, 2003). Randomized data is lacking for Quetiepine in older adults.…”
Section: Discussionmentioning
confidence: 81%
“…Olanzapine was associated with more frequent falls in patients with dementia than Risperidone (Martin et al, 2001b), although no differences in falls were found in another similar study (Kennedy et al, 2003). No differences in clinical (Jeste et al, 2003) or cognitive (Harvey et al, 2003) outcomes were found in randomized comparisons of Risperidone and Olanzapine in elderly patients with schizophrenia or schizoaffective disorder, although weight gain was found more commonly in patients treated with Olanzapine in one of these studies (Jeste et al, 2003). Randomized data is lacking for Quetiepine in older adults.…”
Section: Discussionmentioning
confidence: 81%
“…Finally, although antipsychotics have been associated with modest improvement in cognition in some studies of patients with schizophrenia [28][29][30], they have also been associated with adverse cognitive effects across a wide range of doses [31][32][33]. Such adverse effects are particularly relevant in older adults considering that patients with schizophrenia demonstrate persistent or worsening cognitive deficits with age [34].…”
Section: Adverse Effectsmentioning
confidence: 92%
“…Second generation agents (atypical antipsychotics), such as clozapine 6, olanzapine, ziprasidone, and risperidone, have reduced extrapyramidal side effects (EPS) and tardive dyskinesia (TD) compared to first-generation treatments. Although some of the atypical antipsychotics have been found to improve cognitive function, overall this is modest and not always consistent [Bilder et al, 2002;Goldberg et al, 1993;Harvey and Keefe, 2001;Harvey et al, 2003Harvey et al, , 2004Harvey et al, , 2005Keefe et al, 2004].…”
Section: Introductionmentioning
confidence: 94%